Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer

Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths with high morbidity and mortality. Non–small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 85% of all cases. Fortunately, the development of molecular oncology provides a promising and effective therapeutic s...

Full description

Bibliographic Details
Main Authors: Dehua Liao, Lun Yu, Dangang Shangguan, Yongchang Zhang, Bowen Xiao, Ni Liu, Nong Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
combination treatment
sequential treatment
NSCLC
TKIs
ICIs
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.905947/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.905947/full

Similar Items